The US regulator has approved Waskyra (etuvetidigene autotemcel), the first gene-correcting therapy for Wiskott-Aldrich ...

Sarepta Therapeutics (NASDAQ:SRPT) leads in genetic therapies, contributing to ongoing discussions surrounding the nasdaq ...

Rocket Pharmaceuticals (NASDAQ:RCKT) advances gene-therapy innovation and appears in broader discussions involving the nasdaq ...

Expression Therapeutics, Inc., a clinical-stage biopharmaceutical company developing next-generation cellular therapies, today announced the appointment of David F. Townson, Ph.D., as Chief Executive ...

This article explores how challenges such as sequence optimization, immune activation and off-target effects are being ...

Since the identification of Apolipoprotein E (APOE) ε4 as the strongest genetic risk factor for Alzheimer's Disease (AD), it has served as a critical marker for predicting disease susceptibility.

Arpita Bose and Zhecheng Zhang explore genetic tools in environmental microbes, citing applications in extracellular electron transfer ...

This study shows that vacancy-engineered MoS₂ nanoflowers drive mitochondrial biogenesis in human mesenchymal stem cells by ...

Amyotrophic lateral sclerosis (ALS) affects nerve cells in the brain and spinal cord. The authors' approach to use genetic code expansion to tag two ALS proteins associated with stress granules has ...